Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice |
Oh, Keunhee
(Laboratory of Immunology and Cancer Biology, Department of Biomedical Sciences, Seoul National University College of Medicine)
Seo, Myung Won (Laboratory of Immunology and Cancer Biology, Department of Biomedical Sciences, Seoul National University College of Medicine) Kim, Young Whan (Department of Internal Medicine, Seoul National University College of Medicine) Lee, Dong-Sup (Laboratory of Immunology and Cancer Biology, Department of Biomedical Sciences, Seoul National University College of Medicine) |
1 | Wynn, T. A., and T. R. Ramalingam. 2012. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18: 1028-1040. DOI |
2 | Wick, G., C. Grundtman, C. Mayerl, T. F. Wimpissinger, J. Feichtinger, B. Zelger, R. Sgonc, and D. Wolfram. 2013. The immunology of fibrosis. Annu. Rev. Immunol. 31: 107-135. DOI |
3 | Lo Re, S., L. Dumoutier, I. Couillin, C. Van Vyve, Y. Yakoub, F. Uwambayinema, B. Marien, S. van den Brule, J. Van Snick, C. Uyttenhove, B. Ryffel, J. C. Renauld, D. Lison, and F. Huaux. 2010. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J. Immunol. 184: 6367-6377. DOI |
4 | Wilson, M. S., S. K. Madala, T. R. Ramalingam, B. R. Gochuico, I. O. Rosas, A. W. Cheever, and T. A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207: 535-552. DOI |
5 | Oh, K., H. B. Park, O. J. Byoun, D. M. Shin, E. M. Jeong, Y. W. Kim, Y. S. Kim, G. Melino, I. G. Kim, and D. S. Lee. 2011. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J. Exp. Med. 208: 1707-1719. DOI |
6 | Ishijima, M., S. R. Rittling, T. Yamashita, K. Tsuji, H. Kurosawa, A. Nifuji, D. T. Denhardt, and M. Noda. 2001. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J. Exp. Med. 193: 399-404. DOI |
7 | Wang, K. X., and D. T. Denhardt. 2008. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19: 333-345. DOI |
8 | Chakraborty, G., S. Jain, and G. C. Kundu. 2008. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 68: 152-161. DOI |
9 | Ahmed, M., R. Behera, G. Chakraborty, S. Jain, V. Kumar, P. Sharma, A. Bulbule, S. Kale, S. Kumar, R. Mishra, R. Raja, S. Saraswati, R. Kaur, G. Soundararajan, D. Kumar, D. Thorat, M. Sanyal, A. Ramdasi, P. Ghosh, and G. C. Kundu. 2011. Osteopontin: a potentially important therapeutic target in cancer. Expert Opin. Ther. Targets 15: 1113-1126. DOI |
10 | Yamamoto, N., F. Sakai, S. Kon, J. Morimoto, C. Kimura, H. Yamazaki, I. Okazaki, N. Seki, T. Fujii, and T. Uede. 2003. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112: 181-188. DOI |
11 | Weber, G. F., S. Ashkar, M. J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512. DOI |
12 | Kanayama, M., D. Kurotaki, J. Morimoto, T. Asano, Y. Matsui, Y. Nakayama, Y. Saito, K. Ito, C. Kimura, N. Iwasaki, K. Suzuki, T. Harada, H. M. Li, J. Uehara, T. Miyazaki, A. Minami, S. Kon, and T. Uede. 2009. Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J. Immunol. 182: 8015-8025. DOI |
13 | Diao, H., K. Iwabuchi, L. Li, K. Onoe, L. Van Kaer, S. Kon, Y. Saito, J. Morimoto, D. T. Denhardt, S. Rittling, and T. Uede. 2008. Osteopontin regulates development and function of invariant natural killer T cells. Proc. Natl. Acad. Sci. U. S. A. 105: 15884-15889. DOI |
14 | Morimoto, J., S Kon, Y. Matsui, and T. Uede. 2010. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr. Drug Targets 11: 494-505. DOI |
15 | Diao, H., S. Kon, K. Iwabuchi, C. Kimura, J. Morimoto, D. Ito, T. Segawa, M. Maeda, J. Hamuro, T. Nakayama, M. Taniguchi, H. Yagita, L. K. Van Kaer, Onoe, D. Denhardt, S. Rittling, and T. Uede. 2004. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21: 539-550. DOI |
16 | Chung, J. W., M S. Kim, Z. H. Piao, M. Jeong, S. R. Yoon, N. Shin, S. Y. Kim, E. S. Hwang, Y. Yang, Y. H. Lee, Y. S. Kim, and I. Choi. 2008. Osteopontin promotes the development of natural killer cells from hematopoietic stem cells. Stem Cells 26: 2114-2123. DOI |
17 | Weber, C. E., N. Y. Li, P. Y. Wai, and P. C. Kuo. 2012. Epithelial-mesenchymal transition, TGF-, and osteopontin in wound healing and tissue remodeling after injury. J. Burn. Care Res. 33: 311-318. DOI |
18 | Liaw. L., D. E. Birk, C. B. Ballas, J. S. Whitsitt, J. M. Davidson, and B. L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101: 1468-1478. DOI |
19 | Konno, S., M. Kurokawa, T. Uede, M. Nishimura, and S. K. Huang. 2011. Role of osteopontin, a multifunctional protein, in allergy and asthma. Clin. Exp. Allergy 41: 1360-1366. DOI |
20 | Pardo, A., K. Gibson, J. Cisneros, T. J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski. 2005. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2: e251. DOI |
21 | Cantor, H., and M. L. Shinohara. 2009. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol. 9: 137-141. DOI |
22 | Kelly, M. M., R. Leigh, S. E. Gilpin, E. Cheng, G. E. Martin, K. Radford, G. Cox, and J. Gauldie. 2006. Cell-specific gene expression in patients with usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 174: 557-565. DOI |
23 | Takahashi, F., K. Takahashi, T. Okazaki, K. Maeda, H. Ienaga, M. Maeda, S. Kon, T. Uede, and Y. Fukuchi. 2001. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 24: 264-271. DOI |
24 | Shinohara, M. L., L. Lu, J. Bu, M. B. Werneck, K. S. Kobayashi, L. H. Glimcher, and H. Cantor. 2006. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 7: 498-506. DOI |
25 | Baroni G. S., L. D'Ambrosio, P. Curto, A. Casini, R. Mancini, A. M. Jezequel, and A. Benedetti. 1996. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23: 1189-1199. DOI |
26 | Giri, S. N., D. M. Hyde, and B. J. Marafino Jr. 1986. Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. Biochem. Med. Metab. Biol. 36: 194-197. DOI |
27 | Oldroyd, S. D., G. L. Thomas, G. Gabbiani, and A. M. EI Nahas. 1996. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 56: 2116-2127. |
28 | Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864. DOI |
29 | Shinohara, M. L., J. H. Kim, V. A. Garcia, and H. Cantor. 2008. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29: 68-78. DOI |
30 | Murugaiyan, G., A. Mittal, and H. L. Weiner. 2010. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc. Natl. Acad. Sci. U. S. A. 107: 11495-11500. DOI |
31 | Wynn, T. A., 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594. DOI |
32 | Braun, R. K., C. Ferrick, P. Neubauer, M. Sjoding, A. Sterner-Kock, M. Kock, L. Putney, D. A. Ferrick, D. M. Hyde, and R. B. Love. 2008. IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 31: 167-179. DOI |
33 | Simonian, P. L., C. L. Roark, F. Diaz del Valle, B. E. Palmer, I. S. Douglas, K. Ikuta, W. K. Born, R. L. O'Brien, and A. P. Fontenot. 2006. Regulatory role of gammadelta T cells in the recruitment of and T cells to lung and subsequent pulmonary fibrosis. J. Immunol. 177: 4436-4443. DOI |
34 | Wynn, T. A. 2011. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208: 1339-1350. DOI |
35 | Brown, L. F., B. Berse, L. Van de Water, A. Papadopoulos-Sergiou, C. A. Perruzzi, E. J. Manseau, H. F. Dvorak, and D. R. Senger. 1992. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 3: 1169-1180. DOI |
36 | Berman, J. S., D. Serlin, X. Li, G. Whitley, J. Hayes, D.C. Rishikof, D. A. Ricupero, L. Liaw, M. Goetschkes, and A. W. O'Regan. 2004. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1311-1318. DOI |
37 | Simonian, P. L., F. Wehrmann, C. L. Roark, W. K. Born, R. L. O'Brien, and A. P. Fontenot. 2010. cells protect against lung fibrosis via IL-22. J. Exp. Med. 207: 2239-2253. DOI |
38 | Sonnenberg, G. F., M. G. Nair, T. J. Kirn, C. Zaph, L. A. Fouser, and D. Artis. 2010. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 207: 1293-12305. DOI |
39 | Katagiri, Y. U., J. Sleeman, H. Fujii, P. Herrlich, H. Hotta, K. Tanaka, S. Chikuma, H. Yagita, K. Okumura, M. Murakami, I. Saiki, A. F. Chambers, and T. Uede. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59: 219-226. |
40 | Ashizawa, N., K. Graf, Y. S. Do, T. Nunohiro, C. M. Giachelli, W. P. Meehan, T. L. Tuan, W. A. Hsueh. 1996. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J. Clin. Invest. 98: 2218-2227. DOI |